Instead of letting her depression run her life, she decided to outrun it.
“I have clinical depression,” says Mara Suttman-Lea. “No, I am not depressed. I suffer from depression. They are two vastly different concepts.”
This study is testing to see what behavior and brain function can tell us about treatment success in depression using cognitive-behavioral therapy, a standard psychotherapy treatment for depressive disorders.
The study purpose is to evaluate what brain function can tell us about treatment success in anxiety disorders.
Time commitment is about 33 hours over 22 visits.
Volunteers will participate in the following:
18 to 25 years old
Suffering from depression
18 to 55 years old
Suffering from an anxiety disorder
Volunteers may not have metal in their body.
6 CE or CME
Ticketed event (includes lunch):
ADAA mourns the loss of Robin Williams and too many others whose lives have ended due to suicide. His tragic death illustrates the great need for increased public awareness of the grave risk that suicide poses.
The purpose of the current study is to evaluate the efficacy of d-cycloserine in augmenting treatment of smoking cessation for individuals with panic attacks. Individuals will receive 7 weeks of panic- and smoking-reduction treatment (PSRT) and one pill of d-cycloserine (DCS) or one pill placebo one hour prior to sessions 3, 4, and 5 (i.e., 3 single doses). Participants will also be given nicotine replacement therapy as part of PSRT (i.e., the patch).
Read Huffington Post blog posts written by ADAA members: